Hans C Korting

Summary

Affiliation: University of Munich
Country: Germany

Publications

  1. ncbi Different skin thinning potential of equipotent medium-strength glucocorticoids
    Hans Christian Korting
    Klinik und Poliklinik fur Dermatologie und Allergologie, Ludwig Maximilians Universitat, Munich, Germany 80337
    Skin Pharmacol Appl Skin Physiol 15:85-91. 2002
  2. ncbi [Fungi overall! Skin and mucosal mycoses and their treatment]
    Hans C Korting
    ,
    Pharm Unserer Zeit 32:130-7. 2003
  3. ncbi The secreted aspartyl proteinases Sap1 and Sap2 cause tissue damage in an in vitro model of vaginal candidiasis based on reconstituted human vaginal epithelium
    Martin Schaller
    Department of Dermatology and Allergology, University of Munich, Germany
    Infect Immun 71:3227-34. 2003
  4. ncbi Effect of antimycotic agents on the activity of aspartyl proteinases secreted by Candida albicans
    Martin Schaller
    Department of Dermatology and Allergology, University of Munich, Frauenlobstr 9 11, D 80337 Munich, Germany
    J Med Microbiol 52:247-9. 2003
  5. ncbi Cytokine expression induced by Candida albicans in a model of cutaneous candidosis based on reconstituted human epidermis
    Martin Schaller
    Department of Dermatology and Allergology, University of Munich, Germany
    J Med Microbiol 51:672-6. 2002
  6. ncbi Infection of human oral epithelia with Candida species induces cytokine expression correlated to the degree of virulence
    Martin Schaller
    Department of Dermatology and Allergology, Ludwig Maximilians University Munich, Germany
    J Invest Dermatol 118:652-7. 2002
  7. ncbi The crystal structure of the secreted aspartic proteinase 3 from Candida albicans and its complex with pepstatin A
    Claudia Borelli
    Department of Dermatology and Allergy, Ludwig Maximilian University of Munich, Frauenlobstr 9 11, 80337 Munich, Germany
    Proteins 68:738-48. 2007
  8. ncbi [Grover's disease following hemodialysis in a patient with renal failure]
    Martina Moderer
    Klinik und Poliklinik für Dermatologie und Allergologie der Universität München
    J Dtsch Dermatol Ges 2:203-5. 2004
  9. ncbi [Comparison of activity of different topical corticosteroid creams and ointments using a vasoconstriction assay: superiority of hydrocortisone butyrate over hydrocortisone]
    Hans Christian Korting
    Klinik und Poliklinik fur Dermatologie und Allergologie, Klinikum der Universitat Munchen, Germany
    J Dtsch Dermatol Ges 3:348-53. 2005
  10. ncbi Cyproterone acetate loading to lipid nanoparticles for topical acne treatment: particle characterisation and skin uptake
    Jana Stecová
    Institut fur Pharmazie, Freie Universitat Berlin, Konigin Luise Strasse 2 4, D 14195, Berlin, Germany
    Pharm Res 24:991-1000. 2007

Collaborators

Detail Information

Publications38

  1. ncbi Different skin thinning potential of equipotent medium-strength glucocorticoids
    Hans Christian Korting
    Klinik und Poliklinik fur Dermatologie und Allergologie, Ludwig Maximilians Universitat, Munich, Germany 80337
    Skin Pharmacol Appl Skin Physiol 15:85-91. 2002
    ..Prednicarbate is a topical glucocorticoid with an improved benefit/risk ratio, as it causes less skin atrophy than the equipotent betamethasone 17-valerate...
  2. ncbi [Fungi overall! Skin and mucosal mycoses and their treatment]
    Hans C Korting
    ,
    Pharm Unserer Zeit 32:130-7. 2003
  3. ncbi The secreted aspartyl proteinases Sap1 and Sap2 cause tissue damage in an in vitro model of vaginal candidiasis based on reconstituted human vaginal epithelium
    Martin Schaller
    Department of Dermatology and Allergology, University of Munich, Germany
    Infect Immun 71:3227-34. 2003
    ..In contrast the vaginopathic potential of mutants lacking SAP3 or SAP4 to SAP6 was not reduced compared to wild-type cells. These data provide further evidence for a crucial role of Sap1 and Sap2 in C. albicans vaginal infections...
  4. ncbi Effect of antimycotic agents on the activity of aspartyl proteinases secreted by Candida albicans
    Martin Schaller
    Department of Dermatology and Allergology, University of Munich, Frauenlobstr 9 11, D 80337 Munich, Germany
    J Med Microbiol 52:247-9. 2003
    ..001). These results point to a multiple effect of this antimycotic agent and might explain the reduced adherence of C. albicans to human epithelial cells at subinhibitory doses...
  5. ncbi Cytokine expression induced by Candida albicans in a model of cutaneous candidosis based on reconstituted human epidermis
    Martin Schaller
    Department of Dermatology and Allergology, University of Munich, Germany
    J Med Microbiol 51:672-6. 2002
    ..These immunomodulatory and morphological similarities might reflect a common pathogenesis factor in both diseases...
  6. ncbi Infection of human oral epithelia with Candida species induces cytokine expression correlated to the degree of virulence
    Martin Schaller
    Department of Dermatology and Allergology, Ludwig Maximilians University Munich, Germany
    J Invest Dermatol 118:652-7. 2002
    ....
  7. ncbi The crystal structure of the secreted aspartic proteinase 3 from Candida albicans and its complex with pepstatin A
    Claudia Borelli
    Department of Dermatology and Allergy, Ludwig Maximilian University of Munich, Frauenlobstr 9 11, 80337 Munich, Germany
    Proteins 68:738-48. 2007
    ..Inhibitor binding causes active site closure by the movement of a flap segment. Comparison of the structures of Sap3 and Sap2 identifies elements responsible for the specificity of each isoenzyme...
  8. ncbi [Grover's disease following hemodialysis in a patient with renal failure]
    Martina Moderer
    Klinik und Poliklinik für Dermatologie und Allergologie der Universität München
    J Dtsch Dermatol Ges 2:203-5. 2004
    ..There are only few case reports in the literature describing Grover's disease occurring during hemodialysis treatment. All such previous patients have been men; ours is the first woman...
  9. ncbi [Comparison of activity of different topical corticosteroid creams and ointments using a vasoconstriction assay: superiority of hydrocortisone butyrate over hydrocortisone]
    Hans Christian Korting
    Klinik und Poliklinik fur Dermatologie und Allergologie, Klinikum der Universitat Munchen, Germany
    J Dtsch Dermatol Ges 3:348-53. 2005
    ..Topical corticosteroids are the treatment of choice for numerous inflammatory or hyperproliferative skin diseases. The vasoconstriction assay is suitable to determinate corticosteroid activity...
  10. ncbi Cyproterone acetate loading to lipid nanoparticles for topical acne treatment: particle characterisation and skin uptake
    Jana Stecová
    Institut fur Pharmazie, Freie Universitat Berlin, Konigin Luise Strasse 2 4, D 14195, Berlin, Germany
    Pharm Res 24:991-1000. 2007
    ..To improve skin penetration of the poorly absorbed drug, we intended to identify the active moiety and to load it to particulate carrier systems...
  11. ncbi Hydroxyethyl starch-induced itch: relevance of light microscopic analysis of semi-thin sections and electron microscopy
    Stefanie Kamann
    Clinic and Polyclinic for Dermatology and Allergology, Ludwig Maximilian University, Munich, Germany
    J Dtsch Dermatol Ges 5:204-8. 2007
    ..Our aim was to compare electron microscopic search for HES deposits with other techniques...
  12. ncbi [Cellulite--the greatest skin problem in healthy people? An approach]
    Tatjana Pavicic
    Klinik und Poliklinik fur Dermatologie und Allergologie, Klinikum der Universitat Munchen, Germany
    J Dtsch Dermatol Ges 4:861-70. 2006
    ..The latter approach has been evidence-based with respect to caffeine liposomal cream and retinol cream...
  13. ncbi [Topical skin therapy with glucocorticoids--therapeutic index]
    Thomas Luger

    J Dtsch Dermatol Ges 2:629-34. 2004
  14. ncbi Xerosis and callus formation as a key to the diabetic foot syndrome: dermatologic view of the problem and its management
    Tatjana Pavicic
    Klinik und Poliklinik fur Dermatologie und Allergologie, Klinikum der Ludwig Maximilians Universität, D 80337 München, Germany
    J Dtsch Dermatol Ges 4:935-41. 2006
    ..The most important therapeutic goals are optimal control of the diabetes mellitus, relieving pressure points and avoiding or reducing callus formation...
  15. ncbi Tinea capitis
    Claus Seebacher
    J Dtsch Dermatol Ges 4:1085-91. 2006
  16. ncbi [Oral candidiasis]
    Dieter Reinel
    Bundeswehrkrankenhaus Hamburg, Abt. f. Dermatologie, Venerologie und Allergologie
    J Dtsch Dermatol Ges 2:874-6. 2004
  17. ncbi [Use of Lactobacillus as a probiotic factor to treat urogenital and intestinal infections as well as to prevent and treat allergic diseases]
    Kathrin Merk
    Klinikum der Universitat Munchen, Klinik und Poliklinik für Dermatologie und Allergologie Innenstadt
    J Dtsch Dermatol Ges 2:752-7. 2004
    ..The preventive and therapeutic effect of lactobacilli applies to diarrhoea and urogenital infections in particular. Lactobacilli also seem to have a protective influence on the development and treatment of atopic disease...
  18. ncbi Sphingosine-1-phosphate signaling and the skin
    Thomas Herzinger
    Klinik und Poliklinik fur Dermatologie und Allergologie, Ludwig Maximilian University, Munich, Germany
    Am J Clin Dermatol 8:329-36. 2007
    ..Topical use of S1P and other sphingosine compounds is also under investigation, particularly for the treatment of acne vulgaris...
  19. ncbi Improved differentiation of benign and malignant lymphadenopathy in patients with cutaneous melanoma by contrast-enhanced color Doppler sonography
    Monika Hildegard Schmid-Wendtner
    Department of Dermatology and Allergology, Ludwig Maximilians University, Frauenlobstr 9 11, D 80337 Munich, Germany
    Arch Dermatol 138:491-7. 2002
    ....
  20. ncbi Ciclopirox olamine treatment affects the expression pattern of Candida albicans genes encoding virulence factors, iron metabolism proteins, and drug resistance factors
    Markus Niewerth
    Robert Koch-Institut, 13353 Berlin, Germany
    Antimicrob Agents Chemother 47:1805-17. 2003
    ..Furthermore, neither the expression of certain multiple-drug resistance genes nor other resistance mechanisms caused C. albicans resistance to this drug even after long-term exposure...
  21. ncbi Retinoids in the treatment of skin aging: an overview of clinical efficacy and safety
    Siddharth Mukherjee
    Department of Pharmacology, Bombay College of Pharmacy, Kalina, Santacruz (E, Mumbai, India
    Clin Interv Aging 1:327-48. 2006
    ..However, more elaborate clinical studies are required to confirm their advantage in the delivery of topical retinoids...
  22. ncbi Comparative study of 2% sertaconazole solution and cream formulations in patients with tinea corporis, tinea pedis interdigitalis, or a corresponding candidosis
    Claudia Borelli
    Department of Dermatology and Allergology, Ludwig Maximilian University, Munich, Germany
    Am J Clin Dermatol 8:371-8. 2007
    ..Based on the results of numerous preclinical and clinical studies, sertaconazole can be considered a safe and effective drug for the treatment of fungal skin infections...
  23. ncbi Oxygen accessibility and iron levels are critical factors for the antifungal action of ciclopirox against Candida albicans
    Hans-Christian Sigle
    , , , , D-14195 Berlin, Germany
    J Antimicrob Chemother 55:663-73. 2005
    ..CONCLUSIONS: These data indicate that metabolic activity, oxygen accessibility and iron levels are critical parameters in the mode of action of ciclopirox olamine...
  24. ncbi Comparable efficacy and safety of various topical formulations of terbinafine in tinea pedis irrespective of the treatment regimen: results of a meta-analysis
    Hans Christian Korting
    Klinik und Poliklinik fur Dermatologie und Allergologie, Ludwig Maximilians Universitat Munchen, Munich, Germany
    Am J Clin Dermatol 8:357-64. 2007
    ....
  25. ncbi Lactobacilli - bacteria-host interactions with special regard to the urogenital tract
    Kathrin Merk
    Klinikum der Universitat Munchen, Klinik und Poliklinik für Dermatologie und Allergologie Innenstadt, Frauenlobstr 9 11, D 8033 7 München, Germany
    Int J Med Microbiol 295:9-18. 2005
    ..This review is aimed to present and discuss results concerning interactions of lactobacilli and immune system or epithelial cells with focus to urogenital mucosa...
  26. ncbi [Maintenance treatment and early intervention--the new paradigm in the management of atopic eczema]
    Hans Christian Korting
    ,
    J Dtsch Dermatol Ges 3:519-23. 2005
  27. ncbi Onychomycosis
    Claus Seebacher
    Dresden, Germany
    J Dtsch Dermatol Ges 5:61-6. 2007
  28. ncbi Human epithelial cells establish direct antifungal defense through TLR4-mediated signaling
    Gunther Weindl
    Department of Dermatology, Eberhard Karls University of Tubingen, Tubingen, Germany
    J Clin Invest 117:3664-72. 2007
    ....
  29. ncbi [Dermatological guideline efforts for 2007 in perspective]
    Hans Christian Korting
    J Dtsch Dermatol Ges 5:1-3. 2007
  30. ncbi Toll-like receptors and innate antifungal responses
    Alexander Roeder
    Department of Dermatology, Ludwig-Maximilians-University, 80337 Munich, Germany
    Trends Microbiol 12:44-9. 2004
    ....
  31. ncbi Toll-like receptors as key mediators in innate antifungal immunity
    Alexander Roeder
    Department of Dermatology and Allergology, Ludwig-Maximilian University, Munich, Germany
    Med Mycol 42:485-98. 2004
    ..Recent evidence further suggests that TLRs cooperate with other immune receptors involved in fungal recognition and that the selective induction of adaptor proteins finally leads to distinct signalling events upon fungal challenge...
  32. ncbi Human defensins
    Josef Johann Schneider
    Klinik und Poliklinik fur Dermatologie und Allergologie, Ludwig Maximilians Universitat Munchen, Frauenlobstrasse 9 11, 80337 Munich, Germany
    J Mol Med (Berl) 83:587-95. 2005
    ..Its bactericidal activity against P. aeruginosa is stronger than that of the other known beta-defensins. Here we present an overview of human antimicrobial peptides with some emphasis on their antifungal properties...
  33. ncbi Peroxisome proliferator-activated receptors and their ligands: entry into the post-glucocorticoid era of skin treatment?
    Gunther Weindl
    Department of Dermatology, University of Tubingen, Tubingen, Germany
    Drugs 65:1919-34. 2005
    ..Nonetheless, PPARs seem to have significant potential as therapeutic targets in skin inflammatory disorders...
  34. ncbi [Tinea capitis]
    Claus Seebacher
    J Dtsch Dermatol Ges 2:462-8. 2004
  35. ncbi Individual acid aspartic proteinases (Saps) 1-6 of Candida albicans are not essential for invasion and colonization of the gastrointestinal tract in mice
    Marianne Kretschmar
    , , Theodor-Kutzer-Ufer 1-3, D-68167 Mannheim, Germany
    Microb Pathog 32:61-70. 2002
    ..We conclude that although Saps were produced, individual Saps were not indispensable factors for virulence during gastrointestinal infection of mice...
  36. ncbi Receptor-selective retinoids for psoriasis: focus on tazarotene
    Gunther Weindl
    Department of Dermatology, University of Tubingen, Tubingen, Germany
    Am J Clin Dermatol 7:85-97. 2006
    ..Moreover, the major drawback of oral tazarotene is teratogenicity, which may limit its use in female patients. Further studies evaluating long-term clinical outcomes with oral tazarotene and its use in combination therapies are awaited...
  37. ncbi Reconstructed human epidermis for skin absorption testing: results of the German prevalidation study
    Monika Schäfer-Korting
    Freie Universitat Berlin, Institut fur Pharmazie, Konigin Luise Strasse 2 4, 14195 Berlin, Germany
    Altern Lab Anim 34:283-94. 2006
    ..Long and variable lag times, which are a matter of concern when using human and pig skin, did not occur with RHE. Due to the successful transfer of the protocol, it is now in the validation process...
  38. ncbi The use of reconstructed human epidermis for skin absorption testing: Results of the validation study
    Monika Schäfer-Korting
    Freie Universitat Berlin, Institut fur Pharmazie, Berlin, Germany
    Altern Lab Anim 36:161-87. 2008
    ..Thus, the RHE models, EPISKIN, EpiDerm and SkinEthic, are appropriate alternatives to human and pig skin, for the in vitro assessment of the permeation and penetration of substances when applied as aqueous solutions...